9 September - 11 September 2024
Organised by:
SCI's Fine Chemicals Group and RSC's Biological & Medicinal Chemistry Sector
Cranfield Management Development Centre, UK
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (e.g. dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.
This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation.
The programme can be viewed here.
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Abstract submission is open, click here to submit.
The oral submission deadline has now passed, but poster applications are still being accepted.
For further information click here.
Cranfield Management Development Centre
Cranfield University
Milton Keynes
UK
Hg3 Conferences Ltd
Tel: +44 (0)1423529333
Email: events@hg3.co.uk
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations